Search

everythinglearnresearchcommunity

for

Search:↓

Overexpressing the human H-ferritin gene in mice causes mild growth delay and temporary hair loss.

A genetic mutation in the CDH3 gene causes hair loss and vision problems in a young Saudi girl.

A woman thought to have rosacea was actually suffering from Frontal Fibrosing Alopecia, a hair loss condition. Despite treatment, her condition didn't change, showing the importance of accurate early diagnosis.

Certain microRNAs might help identify and understand Frontal Fibrosing Alopecia.

Folliculotropic mycosis fungoides has a worse prognosis than other types, with survival rates varying significantly based on subtype and organ involvement.

Familial dyskeratotic comedones are a rare, benign skin disorder that is hard to treat.

Combination therapy helped patient with advanced Hidradenitis Suppurativa achieve remission.

Certain miRNAs might be involved in a hair loss condition called frontal fibrosing alopecia and could possibly help in its diagnosis.

Some overweight or obese men with long-term frontal fibrosing alopecia may have abnormal sex hormone levels.

Early recognition of skin lesions in Birt-Hogg-Dubé syndrome is crucial for detecting renal tumors early.

Some postmenopausal women with frontal fibrosing alopecia stopped losing hair with finasteride treatment, hinting at a possible hormonal cause.

The document concludes that Functional Hypothalamic Amenorrhea should be carefully diagnosed and managed to prevent health complications, using lifestyle changes and specific medications.

Folliculotropic mycosis fungoides can occur in children and is diagnosed with specific tests, but often stays in early stages with treatment.

FFA and FAPD might be related or stages of the same disease.

Ultrasonic microneedles improve hair regrowth treatment effectiveness without side effects.

Frontal fibrosing alopecia is a poorly understood condition with increasing cases and unclear treatment effectiveness.

The research found that a specific gene mutation causes fewer hair follicles and disrupted hair growth cycles, leading to thin and short hair in people with Hypotrichosis with Juvenile Macular Dystrophy.

Frontal Fibrosing Alopecia involves disrupted cholesterol pathways, fibrosis, and increased mast cells.

Folliculotropic mycosis fungoides has unique molecular features and cell interactions that could guide targeted therapy.

Frontal fibrosing alopecia is a challenging hair loss condition with no known cause or definitive treatment.

Frontal fibrosing alopecia often occurs after menopause, with delayed diagnosis and possible links to certain medications and conditions.

Folliculotropic Mycosis Fungoides requires stage-based treatment, with early stages using skin therapies and advanced stages needing aggressive treatments.

Early diagnosis and treatment of frontal fibrosing alopecia are crucial to prevent permanent hair loss.

HS needs personalized treatment plans and more research.

Female pattern hair loss often starts in teenage years, reduces hair density, and can impact quality of life.

Local testosterone treatment improved sexual desire in a female with fragile X syndrome.

Frontal fibrosing alopecia is a scarring hair loss condition mainly affecting older women, with no known cause and treatments that may help stabilize hair loss.

Frontal fibrosing alopecia is increasing, especially in postmenopausal women, and treatment with finasteride can improve it.

Young HS patients often have other physical and mental health issues, and research on HS covers a wide range of topics including genetics, triggers, treatments, and the need for more data.

Renaming frontal fibrosing alopecia to a syndrome could improve diagnosis and treatment.